Silencing of high‐mobility group box 2 (HMGB2) modulates cisplatin and 5‐fluorouracil sensitivity in head and neck squamous cell carcinoma

Publisher: John Wiley & Sons Inc

E-ISSN: 1615-9861|15|2-3|383-393

ISSN: 1615-9853

Source: PROTEOMICS, Vol.15, Iss.2-3, 2015-01, pp. : 383-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract